Ludwigshafen, Germany

Paul Igor Costea

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Basf Se Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Igor Costea. Retrieved from https://idiyas.com/inventor/paul-igor-costea

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paul Igor Costea: Innovator in Heidelberg

Introduction

Paul Igor Costea is a notable inventor based in Heidelberg, Germany. He has made significant contributions to his field, although he currently holds no patents. His work is characterized by a commitment to innovation and collaboration.

Latest Patents

As of now, Paul Igor Costea has not registered any patents. This does not diminish his impact in the research community, as he continues to contribute to various projects and initiatives.

Career Highlights

Throughout his career, Paul has been associated with Bork, Peer, where he has worked alongside esteemed colleagues. His dedication to research and development has positioned him as a valuable asset in his field.

Collaborations

Paul has collaborated with notable figures such as Peer Bork and Julien Tap. These partnerships have allowed him to engage in meaningful research and contribute to advancements in his area of expertise.

Conclusion

In summary, Paul Igor Costea is an influential inventor in Heidelberg, known for his collaborative spirit and commitment to innovation. His journey in the field continues to inspire those around him.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…